Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Infectious Disease Experts from Around the Globe Meet to Discuss Viral Threats at ISHEID This Month
  • USA - English


News provided by

[email protected]

May 05, 2014, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Toulon, France (PRWEB UK) 5 May 2014 -- The International Symposium on HIV and Emerging Infectious Diseases (ISHEID) will take place in Marseille, France, 21-23 May 2014. More than 900 international scientists are expected to challenge current major viral epidemics. The main theme will be, “Together for a World Free of HIV & AIDS.”

“In 2014 viral diseases remain a major cause of death in the world and new strains have the ability to kill millions of people if we do not control their spread,” said Doctor Lafeuillade, President of the ISHEID. “While we have effective therapies for some viruses, with cost issues, we are still unarmed against others. Uniting virologists, immunologists and medical doctors at the ISHEID is a way to move forward,” he added.

Recent findings regarding a potential HIV cure, and future directions, will be addressed by Liang Shan (Baltimore, USA), Ole Schmeltz Sogaard (Aarhus, Denmark), and Jan Van Lunzen (Hamburg, Germany) among others. Human Immunodeficiency Virus (HIV) infects 35 million individuals worldwide. HIV cannot be eradicated yet from an infected host and, without antiretroviral therapy, leads to AIDS and death. In Western countries more than 30 different drugs are available to block HIV replication and stop disease progression. Due to the presence of viral reservoirs containing latent proviruses, this treatment is life- long unless HIV replication rekindles. This implies problems of compliance, resistance, toxicity and cost. Therefore, the search of a HIV functional cure -where HIV replication could be controlled without continuing antiretroviral therapy- is in the front burners.

In sub-saharan Africa and Asia live 29 million individuals infected by HIV. Most of them do not have access to antiretroviral therapy for economic reasons and they spread the epidemic. Ways to control it will be shown by Myron Cohen (Chapel Hill, USA) and Joep Lange (Amsterdam, the Netherlands). One controversial possibility is to use antiretroviral therapy as prevention for people at risk of HIV but not yet infected. The ideal response would be a preventive HIV vaccine. An update on anti-HIV vaccine development will be given by Marc Girard (Paris, France).

Hepatitis C Virus (HCV) infection concerns 350 million individuals worldwide. Without therapy, HCV can induce liver cirrhosis and cancer. 2014 is considered to be the year of the "anti-HCV revolution" as several new antivirals are coming to the market, which can definitively cure up to 90-100 percent of patients. Unlike HIV, HCV can be eradicated. But the cost of one single treatment averages 100,000 euros, meaning that it cannot be implemented in most countries where the majority of patients reside. This dilemma and these new therapeutic tools will be discussed by Jurgen Rockstroh (Bonn, Germany), Vicente Soriano (Madrid, Spain), Marc Bourliere (Marseille, France) and Fabien Zoulim (Lyon, France) among others.

The ISHEID will also address other viral threats such as viral hepatitis E (Henry Dalton, Truro, UK), the new deadly H7N9 flu strain (Bruno Lina, Lyon, France) and the new deadly Middle East Respiratory Syndrome Coronavirus (Marcel Muller, Bonn, Germany).

About the ISHEID
The International Symposium on HIV and Emerging Infectious Diseases (ISHEID) is organized under the auspices of the French Agency for AIDS and viral hepatitis Research (ANRS). The 2012 ISHEID (International Symposium on HIV & Emerging Infectious Diseases) attracted more than 1,000 registrations from 48 countries. It allowed fruitful scientific exchanges in a friendly atmosphere during plenary sessions, hot debates, round tables and symposia. It also had a large media exposure, with articles in scientific journals but also in the news from a lot of local, regional, national and international newspapers. Reports were even broadcasted from the French TV, ARTE, and the German radio.

Press contact: Alain Lafeuillade, MD
Department of infectious Diseases, Toulon, France
Ph: +33 4 94 14 50 84
Email: alain.lafeuillade(at)ch-toulon.fr

Web site: http://www.isheid.com

Alain Lafeuillade, [email protected], +33 494234078, [email protected]

Modal title

2014 ISHEID
2014 ISHEID
Final ISHEID Program
View PDF
Final ISHEID Program
2014 ISHEID Final ISHEID Program

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.